Filter posts

Measuring the Impact of Innovation

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance …

Gene Patent Discussion Should Include Industrial, Environmental, & Ag Biotech

Twenty-three industrial and agricultural biotech companies, ranging from development-stage businesses to all of the largest …

2012 BIO International Convention: Academic and Tech Transfer Community

Universities have historically been on the front lines of translating innovative research into novel medicines …

IP Creates Jobs for America

By Mark Elliot, Executive Vice President, U.S. Chamber of Commerce’s Global Intellectual Property Center In …

Mayo v. Prometheus: Thought Leaders Express Concern and Evaluate the Impact

The Mayo v. Prometheus event hosted at George Washington School of Law with the Biotechnology …

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward is a public round-table event hosted …

American Invents Act Strategies Highlighted at the IPCC Conference

By David Saravitz, Alston + Bird Day 2 of the 2012 BIO Intellectual Property Counsels’ Committee …

Biotech Patent Case Law Updates at the IPCC

By John W. Cox, Counsel at Alston+Bird LLP The Spring 2012 BIO Intellectual Property Counsels’ Committee …

Congressional Hearing on International Patent Issues: BIO Submits Comments

The House Judiciary Committee conducted a hearing on World IP Day on “International Patent Issues: …

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact …